<DOC>
	<DOCNO>NCT00970424</DOCNO>
	<brief_summary>This study evaluate safety efficacy dutogliptin patient type 2 diabetes mellitus ( T2DM ) receive background treatment pioglitazone .</brief_summary>
	<brief_title>Safety Efficacy Dutogliptin Patients With Type 2 Diabetes Mellitus ( T2DM ) Background Therapy With Pioglitazone</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<criteria>Type 2 diabetes mellitus , diagnose least 3 month prior Screening ( Visit 1 ) BMI 20 48 kg/m2 , inclusive HbA1c 7.0 % 10.0 % , inclusive Age 18 85 year , inclusive Currently take one oral hypoglycemic agent Type 1 diabetes mellitus</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>